You are not the only one. If you are reading this with a diagnosis sitting somewhere in the back of your mind — arthritis, type 2 diabetes, a cardiac condition — wondering whether the bike still has a place in your life, you are in very large company.
By the time you reach the 35-55 bracket, chronic conditions stop being rare and start being normal. Roughly 40% of adults over 45 in the UK live with at least one long-term condition. Among the riders I speak to through the Not Done Yet community, this comes up constantly. Not as a fringe question. As one of the most common questions.
I need to be really clear about something, right from the start.
A note before we go any further
I am not a doctor. I am not your doctor. Nothing in this article is medical advice, and nothing in it should replace the guidance of the clinician who knows your specific history, your specific medication, and your specific risk profile.
What this article is: evidence-based information — drawn from peer-reviewed research and clinical guidelines — that you can take to your next appointment and use as a starting point for a conversation with your medical team. Print it out. Highlight the bits that apply to you. But the person who makes the call on your training is the person with your medical records open in front of them. Not me. Not a blog post.
These conditions do not have to stop you riding. But you need to be smart about how you do it.
The case for cycling — not despite your condition, but because of it
The evidence on exercise and chronic disease is not ambiguous any more. The science has finally caught up with what a lot of riders have felt intuitively for years: that getting on the bike makes things better, not worse.
A 2023 umbrella review published in the British Journal of Sports Medicine — covering 16 systematic reviews and over 150 individual studies — concluded that physical activity reduces pain, improves function, and slows disease progression in osteoarthritis. It lowers HbA1c and improves insulin sensitivity in type 2 diabetes. It reduces all-cause mortality and cardiovascular mortality in people with established heart disease.
Cycling, specifically, has advantages that most other exercise modalities do not.
Low-impact. Your knees, hips, and ankles are not absorbing ground reaction forces the way they do in running. For somebody with joint disease, this is the entire reason cycling is the first exercise most rheumatologists recommend.
Scalable. You can ride at 80 watts or 280 watts. You can do 30 minutes or 4 hours. Indoors with total control or outdoors in the fresh air.
Measurable. With a heart rate monitor, a power meter, or a training readiness check, you can track how your body responds day to day — which matters enormously when your condition introduces variability that healthy riders never think about.
Social. Group rides, club spins, the community inside NDY. Isolation is one of the biggest risk factors for poor outcomes in chronic disease, and the bike is one of the best tools for getting out the door and around other people.
Cycling with arthritis
Arthritis is the condition I hear about most often from masters riders. It is almost ubiquitous in the 45+ age group — the Arthritis Foundation estimates that roughly one in four adults has doctor-diagnosed arthritis, and the prevalence climbs with every decade past forty.
The first thing to understand is that not all arthritis is the same.
Osteoarthritis vs rheumatoid arthritis
Osteoarthritis (OA) is the wear-and-tear form. Cartilage in the joint breaks down over time, leading to pain, stiffness, and sometimes swelling. It most commonly affects the knees, hips, and hands. This is the one most cyclists deal with. It gets worse with inactivity and better with appropriate movement.
Rheumatoid arthritis (RA) is an autoimmune condition where the immune system attacks the joint lining. It causes inflammation, pain, and fatigue — and the fatigue can be crushing. Flares are unpredictable. The disease activity is managed with immunosuppressant medication, and the exercise prescription needs to account for both the joint symptoms and the systemic fatigue.
Both conditions benefit from cycling. But the way you approach riding differs depending on which one you have.
Why cycling is ideal for arthritic joints
A 2015 Cochrane review of 54 randomised controlled trials found that land-based exercise — including cycling — produced clinically significant reductions in pain and improvements in physical function for people with knee osteoarthritis. The effect sizes were comparable to non-steroidal anti-inflammatory drugs (NSAIDs), without the gastrointestinal side effects.
The mechanism is simple. Articular cartilage has no blood supply. It relies on compression and release during movement to draw nutrients from surrounding synovial fluid. When you pedal, the rhythmic loading and unloading pumps synovial fluid through the cartilage — feeding it, slowing degradation. Stop moving, and the cartilage starves.
Research published in Arthritis & Rheumatology (2017) showed that moderate cycling three times per week for 12 weeks reduced knee pain scores by 40% in adults with knee OA. Participants who exercised had better cartilage quality on MRI scans at follow-up than those who rested.
Resting does not protect arthritic joints. Appropriate movement does.
Bike fit considerations for arthritis
This is where it gets really interesting, because bike fit matters more for arthritic riders than for anyone else on the road.
Saddle height. Too high and you overextend the knee on every stroke. Too low and you compress the kneecap into the femoral groove under load — the worst possible thing for patellofemoral OA. The sweet spot is a knee angle of 25-30 degrees at full extension. If you have not had a professional bike fit, get one. Arthritic joints change over time and the fit that worked two years ago may not work now. Our knee pain guide covers the key measurements.
Crank length. Shorter cranks reduce the range of motion your knee goes through on every revolution. For riders with significant knee OA, dropping from 172.5mm to 165mm cranks can be transformative — less flexion at the top of the stroke means less compression where it hurts most. One of the most underused interventions in cycling for arthritis.
Gearing. Grind less. Spin more. A cadence of 80-95 RPM puts substantially less torque through the knee per revolution than grinding at 60-70 RPM. The total work output is identical — you just spread it across more revolutions with less force each time.
Handlebar reach. Wrist and hand arthritis is common and overlooked. If your hands go numb, ache, or stiffen during rides, the reach may be too long, the bars too narrow, or the grip angle wrong. Ergonomic grips, wider bars, or a shorter stem can reduce wrist extension.
When to ride and when to rest
This is the question arthritic cyclists ask most, and the answer is less binary than most people expect.
Morning stiffness is normal. OA joints are stiff when you wake up — usually for 20-30 minutes. This does not mean you cannot ride. It means you need a longer warm-up. Start with 10-15 minutes of very easy spinning before asking anything of your legs.
Swelling is a signal. A joint that is warm, puffy, and visibly swollen after a ride — and stays that way for more than 24 hours — tells you the previous ride was too much. Reduce duration or intensity by 20-30% on the next ride and see if the swelling resolves.
Pain during the ride is information. A dull ache that settles into the background after 15 minutes is usually fine — that is the joint warming up and the synovial fluid doing its work. Sharp pain that gets worse as you ride is a red flag. Stop. Do not push through sharp, escalating joint pain.
RA flares require a different response. If you have rheumatoid arthritis and you are in a flare — joints hot, fatigue through the floor, inflammation markers climbing — riding through it is not tough. It is counterproductive. The systemic inflammation means your immune system is already in overdrive. Rest, manage the flare with your rheumatologist, and come back to the bike when the inflammation subsides.
Heat, cold, and anti-inflammatory nutrition
Before a ride: Warm the affected joints. A hot shower, warm compress, or 10 minutes on the turbo at minimal resistance all work. Warm joints have better synovial fluid viscosity and move with less friction.
After a ride: If a joint is swollen or angry, ice it. 15-20 minutes with a cold pack. This is not about preventing inflammation entirely — some inflammatory response to exercise is normal and healthy. It is about managing excess inflammation in joints that are already compromised.
Nutrition. A 2020 systematic review in Nutrients found that omega-3 fatty acids (from oily fish or supplementation at 2-3g EPA+DHA per day) produced modest but consistent reductions in joint pain and morning stiffness in OA and RA. Not a cure. A marginal gain. But marginal gains compound.
Anti-inflammatory dietary patterns — more oily fish, olive oil, vegetables, nuts, berries; less ultra-processed food, refined sugar, excessive alcohol — show consistent associations with lower inflammatory markers. The basics done consistently.
Cycling with type 2 diabetes
Type 2 diabetes is the other condition I hear about constantly from riders in the 35-55 bracket. The prevalence has roughly doubled in the last two decades, and the onset age keeps creeping lower. If you have been diagnosed, cycling is one of the most effective things you can do — the evidence on that is overwhelming. But the practicalities require thought.
How cycling affects blood glucose
When you ride, your working muscles consume glucose at a dramatically higher rate than at rest. Even moderate cycling can increase glucose uptake by 5-20 times the resting rate. And it does this partly through a mechanism that does not require insulin — muscle contraction itself triggers GLUT4 transporter proteins to move to the cell surface, pulling glucose in without needing the usual insulin key.
This means exercise provides an additional glucose-lowering pathway that works even when your insulin sensitivity is impaired. Research published in Diabetes Care (2021) showed that regular moderate-intensity cycling lowered HbA1c by 0.5-0.7% over 12 weeks. The threshold at which a medication is considered clinically effective is typically a 0.5% reduction. Cycling, done consistently, is a pharmacological-grade intervention.
A single session of moderate cycling improves insulin sensitivity for up to 24-48 hours afterwards. The glucose-lowering benefit extends well beyond the ride itself.
A 2016 meta-analysis in the British Journal of Sports Medicine found that combining aerobic and resistance exercise produced the largest HbA1c reductions — roughly 0.6-0.7%. Cycling covers the aerobic side. Adding two sessions per week of bodyweight or light resistance work (strength training for cyclists covers the essentials) completes the picture.
Timing rides around medication
This is where you absolutely must involve your medical team, because the interaction between exercise and diabetes medication is real and potentially dangerous if managed badly.
Metformin. The most common first-line medication. It does not cause hypoglycaemia on its own, so the risk of a low during riding is minimal. Some riders report GI discomfort if they ride too soon after taking it — leaving 1-2 hours between dose and hard ride is reasonable, but discuss timing with your prescriber.
Sulfonylureas (gliclazide, glimepiride, glipizide). These stimulate the pancreas to produce more insulin regardless of blood glucose level, which means they can cause hypoglycaemia — and exercise amplifies the risk. If you are on a sulfonylurea and cycling regularly, your prescriber may need to reduce the dose on riding days. Do not adjust doses yourself.
Insulin. Exercise increases insulin sensitivity and accelerates glucose uptake. If you inject your usual dose and then ride for two hours, you risk a significant hypo. Most endocrinologists will create a protocol for riding days — typically involving reduced bolus doses, adjusted basal rates (for pump users), or both. Do not freelance. This needs medical input.
SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin). These make the kidneys excrete more glucose in urine. The concern during exercise is dehydration — you are losing fluid through sweat and increased urinary glucose excretion simultaneously. There is also a rare but serious risk of euglycaemic diabetic ketoacidosis (DKA) during prolonged exercise. If you are on an SGLT2 inhibitor and doing rides over 3 hours, discuss this with your diabetes team.
Hypo risk management on the bike
Hypoglycaemia during a ride is the fear that keeps many diabetic cyclists awake. The good news: it is manageable. It requires planning, not panic.
Before the ride. Test blood glucose. Start with glucose between 7-10 mmol/L (126-180 mg/dL). Below 5 mmol/L (90 mg/dL) is too low — eat 15-20g of fast-acting carbohydrate and retest in 15 minutes. Above 14 mmol/L (250 mg/dL), check for ketones; if present, do not ride.
During the ride. Carry glucose tablets or gels accessible within seconds. On rides over 60 minutes, consume 30-60g of carbohydrate per hour — the same fuelling strategy most performance cyclists use (see our carbs per hour guide). For rides over 90 minutes, test blood glucose every 45-60 minutes or use a CGM.
After the ride. Blood glucose can continue to drop for several hours post-ride as glycogen is replenished — the "lag effect." Monitor glucose for 4-6 hours after a long ride. Eat a recovery meal containing carbohydrate and protein within 30-60 minutes.
| Scenario | Blood glucose | Action | |---|---|---| | Pre-ride below 5 mmol/L (90 mg/dL) | Too low to start | Eat 15-20g fast carbs, retest in 15 min | | Pre-ride 5-7 mmol/L (90-126 mg/dL) | Borderline | Eat a small snack before riding | | Pre-ride 7-10 mmol/L (126-180 mg/dL) | Ideal range | Ride with normal fuelling plan | | Pre-ride above 14 mmol/L (250 mg/dL) | Too high | Check ketones; if positive, do not ride | | During ride, feeling shaky or confused | Possible hypo | Stop, test, eat 15-20g fast carbs immediately |
CGM for cyclists — the single best investment
A continuous glucose monitor changes everything for a cyclist with type 2 diabetes. A 2022 study in Lancet Digital Health found that CGM use in type 2 diabetes was associated with a 0.3% additional reduction in HbA1c compared to finger-prick testing alone, largely because of improved time-in-range driven by real-time feedback.
For cyclists, the value is even greater. With a CGM:
- You see your glucose trend before, during, and after rides — not just a snapshot.
- You watch the real-time effect of different intensities. Zone 2 rides typically produce a slow, steady glucose drop. Threshold and VO2 max efforts can spike glucose temporarily (the liver dumps glycogen in response to stress hormones) before a delayed drop.
- You learn your personal patterns. Which rides drop you fastest. How long the post-ride lag effect lasts. Whether morning or evening rides suit your glucose management better.
- Some CGM systems connect to cycling computers, giving you glucose alongside heart rate and power on the same screen.
You go from "I hope my blood sugar stays stable" to "I know my zone 2 rides drop me 2 mmol/L per hour, so I need to fuel accordingly." That is a fundamentally different experience of riding with diabetes.
What the research says about intensity
There is a common assumption that diabetic cyclists should stick to easy riding. The evidence says otherwise.
A 2017 study in Diabetologia found that high-intensity interval training produced larger improvements in insulin sensitivity than moderate continuous cycling — and the effect lasted longer.
This does not mean everybody with type 2 diabetes should be doing VO2 max intervals. It means the intensity spectrum is available to you, provided your medical team agrees and you manage blood glucose around it. As Professor Seiler's research shows, the polarised model — mostly easy riding with small doses of properly hard work — applies to diabetic cyclists just as it does to healthy ones. The principles of training after 40 hold: enough intensity to stimulate adaptation, enough recovery to absorb it.
Cycling with cardiac conditions
This covers riders with coronary artery disease, previous heart attack, cardiac surgery or stenting, atrial fibrillation (AF), or heart failure with preserved ejection fraction.
I need to be really clear about this: cardiac conditions carry the highest risk profile of the three conditions in this article. The guidance here is the most general, because cardiac management is the most individual. Your cardiologist's instructions supersede anything you read here.
Exercise as medicine — the cardiac rehab evidence
The evidence base for exercise after a cardiac event is one of the most robust in all of medicine.
A 2019 Cochrane review covering 63 trials and over 14,000 participants found that exercise-based cardiac rehabilitation reduced cardiovascular mortality by 26%. A meta-analysis in the Journal of the American Heart Association found a 20% reduction in all-cause mortality. A drug that reduced cardiac mortality by 26% would be considered a breakthrough.
Cardiac rehab programmes typically include supervised exercise — often on stationary bikes, which is no coincidence. Cycling allows precise control of workload, continuous HR and rhythm monitoring, and immediate intensity adjustment. Most programmes start at 40-50% of peak heart rate reserve and build over 8-12 weeks.
A 2020 study in the European Journal of Preventive Cardiology found that patients who continued structured exercise after completing formal cardiac rehab maintained their fitness gains and had lower readmission rates at two years. Those who stopped lost the gains within 6-12 months.
Exercise is not optional after a cardiac event. It is treatment.
Heart rate monitoring — and its limitations
Heart rate monitoring is critical for cardiac cyclists. But you need to understand what your numbers mean in the context of your condition and your medication.
Beta-blockers (atenolol, bisoprolol, metoprolol, carvedilol) reduce resting and exercising heart rate. A rider on bisoprolol might have a max HR 20-30 bpm lower than without the drug. Standard heart rate zone calculations — including age-based formulas — are wrong for you. Your HR zones need to be recalculated based on a medically supervised exercise test, not a formula.
Calcium channel blockers (diltiazem, verapamil) also suppress heart rate, though typically less than beta-blockers.
ACE inhibitors and ARBs do not directly affect heart rate but can cause hypotension. Dizziness on standing or when stopping suddenly after a ride may indicate blood pressure dropping too low.
The practical consequence: heart rate is still useful, but it needs clinical context. A heart rate of 130 bpm on a beta-blocker may represent the same physiological stress as 155 bpm without it.
RPE — your most reliable tool
RPE is the one metric unaffected by medication, device calibration, temperature, or caffeine. Simply how hard the effort feels on a 1-10 scale. For cardiac cyclists on beta-blockers, it is often more reliable than heart rate.
| RPE | Description | Cardiac cyclist guidance | |---|---|---| | 1-3 | Easy, conversational | Recovery and base riding. Start here post-rehab | | 4-5 | Moderate, can speak in sentences | The bread and butter of cardiac cycling | | 6-7 | Hard, can speak in short phrases | Only with cardiologist approval | | 8-10 | Very hard to maximal | Generally not recommended without specific clearance |
A 2018 study in the European Journal of Cardiovascular Nursing found that RPE correlated well with objectively measured exercise intensity in cardiac rehab patients, even those on beta-blockers.
If you have power data, RPE plus power gives you two medication-independent intensity markers — more reliable than heart rate alone.
Warning signs that require immediate attention
These are non-negotiable. If any of the following occur during or immediately after a ride, stop riding and seek medical attention:
- Chest pain, pressure, or tightness — even if mild, even if it goes away when you stop
- Unusual breathlessness — beyond what is normal for the intensity level
- Dizziness, lightheadedness, or feeling faint
- Palpitations — a sensation of racing, fluttering, or irregular heartbeat that is new or different from your usual pattern
- Nausea or cold sweating during exercise
- Pain radiating to your jaw, neck, shoulder, or arm
I am not listing these to frighten you. Knowing what to watch for is what lets you ride with confidence. Most cardiac cyclists ride for years without incident — because they know the difference between normal exercise discomfort and a warning sign.
Supervised vs independent training
Most cardiac cyclists begin with supervised exercise and transition to independent training. The timeline depends on your condition, your event, and your cardiologist's assessment. A reasonable progression, supported by BACPR (British Association for Cardiovascular Prevention and Rehabilitation) guidelines:
Phase 1 (weeks 1-6 post-event). Hospital-based rehab. Supervised, very low intensity.
Phase 2 (weeks 6-12). Community-based rehab. Group exercise including stationary cycling. Gradual intensity increases under supervision.
Phase 3 (months 3-6). Transition to independent exercise. Outdoor cycling becomes realistic. Start with flat routes, moderate distances, a riding partner, and your phone.
Phase 4 (6 months+). Long-term maintenance. Structured training becomes possible. The principles Professor Seiler advocates — mostly easy riding with controlled doses of higher intensity — apply, but the intensity ceiling needs your cardiologist's input.
Atrial fibrillation deserves its own mention. AF is increasingly common in masters endurance athletes — a 2017 study in the British Journal of Sports Medicine found a five-fold higher risk in endurance athletes compared to the general population. The exercise prescription depends on whether your AF is paroxysmal, persistent, or permanent, and whether rate and rhythm are well-controlled. Some riders with well-managed AF ride and race at high levels. Others need significant intensity restrictions. This is the most individual of all cardiac conditions.
General principles that apply across all three conditions
Whether you are managing arthritis, diabetes, a cardiac condition, or more than one simultaneously (multimorbidity is the norm in the 45+ age group), several principles apply universally.
Medication timing
Your medication schedule and your riding schedule need to talk to each other.
NSAIDs for arthritis can mask pain signals during a ride — you lose the feedback that tells you when you have done too much. Some riders reserve NSAIDs for after the ride rather than before, so they get honest feedback during the effort. Diabetes and cardiac medications have direct exercise interactions covered above.
The general principle: tell your prescriber that you cycle regularly, how often, and how hard. Ask specifically whether medication timing should change on riding days. Many clinicians do not think to ask about exercise. You need to raise it.
Communication with your medical team
This is the single most important thing in this entire article, and it is the thing most riders do worst.
Your GP, your consultant, your diabetes nurse, your cardiac rehab team — they can only help you if they know what you are doing. "I cycle a bit" is not useful information. "I ride 4-6 hours a week, with one session at high intensity and the rest at conversational pace, and I am planning a 100km sportive in September" gives them something to work with.
Bring data. Heart rate files. Power data. Blood glucose logs. Training stress scores from your training readiness tracking. The more specific you are, the more specific their advice can be.
And ask direct questions. Not "is it okay to cycle?" — that gets vague reassurance. Ask: "Should I adjust the dose on days I ride more than two hours?" Ask: "What heart rate ceiling should I stay below during hard efforts?" Ask: "What symptoms should make me stop mid-ride and call you?"
Training load management
The standard training load principles — progressive overload, periodisation, recovery weeks — apply to riders with chronic conditions. But the margins are narrower.
A healthy 40-year-old might get away with a 15% volume jump. A rider with RA who tries that during elevated disease activity will flare. A cardiac cyclist who adds intervals too aggressively risks an event. A diabetic cyclist who doubles ride duration without adjusting fuel risks a serious hypo.
The 10% rule is the starting point. For riders with chronic conditions, 5-7% weekly load increase is often more appropriate.
Chronic training load (CTL) and acute-to-chronic workload ratio (ACWR) are useful frameworks here. A spike in ACWR — a sudden increase in training load relative to your recent average — is the strongest predictor of injury and illness in endurance athletes. For riders with chronic conditions, it is also a predictor of flares, glucose instability, and cardiac events.
Build slowly. Recover fully. The fitness will come.
The good days and bad days approach
Rigid training plans break riders with chronic conditions.
What most people do: write a plan, follow the plan, feel guilty when the plan does not match their body. What actually works: build a flexible framework with weekly targets and daily choices. On good days — joints quiet, glucose stable, energy present — you do the harder session. On bad days — RA grumbling, blood sugar erratic, fatigue deep — you do the easy spin or you rest. The week still accumulates the work. It just shifts around based on how you feel that day.
This is not weakness. Even at the professional level, as Professor Seiler's research demonstrates, the best athletes adjust daily training based on readiness. For riders with chronic conditions, that flexibility is not optional. It is the system.
A practical framework:
- Set weekly goals, not daily prescriptions. "I want 5 hours of riding this week, including one moderate effort" is better than "Tuesday 90 minutes zone 2, Thursday 60 minutes intervals."
- Check in every morning. How are the joints? What is the blood glucose doing? How did you sleep? How is the fatigue? Give yourself a green/amber/red rating.
- Green: full session, including intensity if planned.
- Amber: reduced duration or intensity. Easy spin instead of intervals. 60 minutes instead of 90.
- Red: rest day. Walk. Stretch. Do not ride. The bike will be there tomorrow.
- Track the pattern. Over weeks and months, the ratio of green to amber to red days tells you something profound about whether your condition is well-managed, whether your training load is appropriate, and whether your medication is working.
Sleep and recovery
Sleep is the most underrated performance variable in cycling — as we have covered in the recovery guide for masters cyclists. For riders with chronic conditions, it is doubly important.
Inflammatory conditions disrupt sleep directly — through pain, cytokines, medication side effects. Poor sleep increases inflammatory markers, which worsens the condition, which worsens sleep further. The cycle is vicious.
Diabetes and sleep have a bidirectional relationship. A 2019 meta-analysis in Sleep Medicine Reviews found that short sleep (less than 6 hours) was associated with a 28% increased risk of developing type 2 diabetes and worsened glycaemic control in those who already had it.
Cardiac conditions — particularly AF — are strongly associated with sleep apnoea. If you have AF and you snore heavily, wake unrefreshed, or your partner notices you stop breathing at night, raise this with your cardiologist.
Prioritise 7-8 hours of sleep with the same intensity you bring to your training. It is not passive recovery. It is active treatment.
Community, support, and the mental side
A diagnosis changes your relationship with cycling. Sometimes for the worse — the anxiety, the uncertainty. Sometimes for the better — the clarity of purpose, the gratitude for what the body can still do, the motivation that comes from knowing the bike is keeping you well.
The riders who manage chronic conditions best do not try to do it alone. They have a medical team they communicate with openly. They have a riding community that understands what they are dealing with. They have a structure that flexes rather than breaks.
Inside Not Done Yet, we have riders managing all three conditions in this article — and several that are not. The value is not that anyone is dispensing medical advice. The value is that someone who has figured out how to manage their CGM on a four-hour ride can share what they learned. Someone who has been through cardiac rehab can tell you what to expect. Someone who rides with RA can tell you which weeks to push and which to back off.
Peer knowledge is not a replacement for medical care. It is a complement. And it makes the whole thing less isolating.
Putting it together
The steps from here are practical and you can go and do them this week:
- Book a conversation with your medical team about your cycling. Bring this article if it helps frame the discussion. Ask the specific questions relevant to your condition.
- Get a bike fit that accounts for your condition. Tell the fitter about your arthritis, your medication, your joint limitations. A good fitter adjusts for these.
- Set up your monitoring. Heart rate monitor at minimum. CGM if you are diabetic. Power meter if budget allows. Use the HR zone calculator as a starting point, but validate zones with your medical team if you are on rate-limiting medication.
- Build a flexible weekly framework. Weekly volume targets with daily flexibility based on how your body shows up.
- Find your people. A riding group, a community, a coach who understands chronic conditions.
The bike is not a cure for arthritis, diabetes, or heart disease. But the evidence is clear: cycling, done intelligently and in partnership with your medical team, is one of the most powerful tools available for managing these conditions, maintaining fitness, and — frankly — enjoying your life.
These conditions do not define what you can do on the bike. They define how you approach it. And that approach, when you get it right, is a framework for riding well for decades to come.